Observational studyHealth and quality of life outcomes2020

Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours.

Halfdan Sorbye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.